Skip to main content
Loading
Sign In
Families and Youth
Toggle
Family Resources
Youth Resources
Facts for Families
Resource Centers
Advocacy
Getting Help
Support AACAP
Medical Students and Residents
Toggle
Medical Student Resources
Child Psychiatry Residents (Fellows)
Early Career Psychiatrists
Member Resources
Toggle
Early Career Psychiatrists
Become a Member
Advocacy
Life Members
Ethics Committee
International
Maintenance of Certification
Clinical Practice Center
Award Opportunities
CPT and Reimbursement
Job Source
Assembly of Regional Organizations
Education Center
Resources for Primary Care
Toggle
Become a Member
Practice Parameters and Resource Centers
Integrating Mental Health Care into the Medical Home
Information for Patients and Their Families
Advocacy and Policy
Clinical Practice Center
CME & Meetings
Toggle
2017 Annual Meeting
2018 Annual Review Course
2016 Annual Meeting
2018 Psychopharmacology Update Institute
Maintenance of Certification and Lifelong Learning Modules
Online CME
Learning on Demand
My Profile
Store
Cart
Donate
About AACAP
Toggle search
Toggle navigation
Quick Links
Family Resources
Resource Centers
Youth Resources
Child and Adolescent Psychiatrist Finder
ADHD Medication
AACAP Testimony at the March 22 FDA Pediatric Advisory Committee Meeting
3/22/06
AACAP Statement on FDA Advisory On Methylphenidate
3/22/06
FDA Statement on Adderall
Canadian Advisory
AACAP President's Email to Members
Cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic Drugs
American Heart Association (see Other Resources below), as reprinted in JAACAP, 1999
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
